IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MAGGI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.892
NA - Nord America 1.048
AS - Asia 575
OC - Oceania 12
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.028
DE - Germania 1.013
GB - Regno Unito 415
CN - Cina 307
SE - Svezia 155
SG - Singapore 117
IT - Italia 115
RU - Federazione Russa 49
HK - Hong Kong 47
IE - Irlanda 42
FR - Francia 28
FI - Finlandia 26
IN - India 26
ID - Indonesia 24
CA - Canada 19
KR - Corea 18
AU - Australia 12
JP - Giappone 11
UA - Ucraina 11
BE - Belgio 9
NL - Olanda 8
DK - Danimarca 6
TH - Thailandia 5
IR - Iran 4
ES - Italia 3
TR - Turchia 3
VN - Vietnam 3
BR - Brasile 2
CH - Svizzera 2
EC - Ecuador 2
EU - Europa 2
GR - Grecia 2
PL - Polonia 2
PT - Portogallo 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 3.537
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 935
Southend 398
Chandler 175
Seattle 88
Fairfield 84
Singapore 79
Milan 77
Ashburn 70
Beijing 65
Wilmington 53
Princeton 48
Cambridge 46
Houston 44
Hong Kong 43
Dublin 40
Woodbridge 40
Munich 33
Phoenix 30
Nanjing 23
Ann Arbor 22
Dearborn 22
Santa Clara 21
Des Moines 19
Jakarta 16
Shenyang 15
Eitensheim 14
San Diego 14
Shanghai 14
Toronto 14
Bengaluru 13
Jinan 12
Guangzhou 10
Brussels 9
Hangzhou 9
Zhengzhou 9
Changsha 8
Falls Church 8
Grafing 8
Nanchang 8
Redwood City 8
Fuzhou 7
Boardman 6
Hebei 6
Helsinki 6
Silver Spring 6
Taiyuan 6
Tokyo 6
New York 5
Amsterdam 4
Andover 4
Chicago 4
Haikou 4
Jiaxing 4
Kunming 4
Los Angeles 4
Ningbo 4
Hefei 3
Langfang 3
Madrid 3
Melbourne 3
Newark 3
Rochester 3
Tianjin 3
Arezzo 2
Berlin 2
Burlington 2
Canberra 2
Carrara 2
Central District 2
Charlotte 2
Clayton 2
Clifton 2
Dallas 2
Hanoi 2
Lanzhou 2
Limerick 2
Naples 2
Paris 2
Piscataway 2
Quanzhou 2
Quito 2
Redmond 2
San Francisco 2
Stockholm 2
Sydney 2
São Paulo 2
Taipei 2
Ankara 1
Anshan 1
Arcadia 1
Athens 1
Atlanta 1
Bangkok 1
Baotou 1
Basel 1
Belgrade 1
Bethesda 1
Boston 1
Brno 1
Central 1
Totale 2.806
Salva come PNG Salva come JPEG
Nome #
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 249
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 221
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status 220
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies 216
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation 178
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 168
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer 162
Single agent panitumumab in kras wild-type metastatic colorectal cancer patients following cetuximab-based regimens 160
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma 156
TP53 mutations in advanced colorectal cancer : the dark side of the moon 156
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 153
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 149
Role of cMET in the development and progression of colorectal cancer 146
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil : a meta-analysis of published trials 143
Role of MGMT as biomarker in colorectal cancer 140
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 140
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab : a meta-analysis 132
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 132
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials 131
Bevacizumab treatment in the elderly patient with metastatic colorectal cancer 127
In reply 119
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer : an Italian Trials of Medical Oncology phase II study 116
Treatment of elderly patients with metastatic renal cell carcinoma 113
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab 96
Totale 3.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 0 0 49 25 50 70 12 7
2020/2021258 10 14 35 31 24 17 7 18 49 17 21 15
2021/2022310 56 10 5 13 20 16 13 13 21 55 13 75
2022/2023508 58 68 55 46 50 85 5 35 77 5 16 8
2023/2024908 4 20 15 8 78 16 137 126 68 156 136 144
2024/2025557 130 115 101 129 51 28 3 0 0 0 0 0
Totale 3.723